First Turn Management, LLC
Filing Date
Global Rank
#2,628
/ 8,795
▼ 228
· as of Jun 2026
Top Industry
Biotechnology
95.1%
3Y Alpha vs SPY
-8.4%
Period ended 3 months ago
Filed Aug 14, 2026 · 54d
11 quarters · since Dec 2023
Clone Performance
Build a hypothetical price-return history from this filer's public 13F holdings.
View clone backtestPortfolio Concentration
31 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
8.4%
+1.0 pts
Top 5
31.4%
+0.8 pts
Top 10
53.8%
+0.5 pts
HHI
423
Diversified+15
Portfolio Trend
11 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 100.0% | $931,467,794 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
14 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| VRDN | Viridian Therapeutics, Inc.\DE | +758,663 | 1,670,000 | $30,677,900 | |
| ERAS | Erasca, Inc. | +354,082 | 1,221,721 | $22,381,928 | |
| ELVN | Enliven Therapeutics, Inc. | +330,521 | 954,360 | $48,433,770 | |
| CYTK | Cytokinetics Inc | +243,712 | 527,412 | $44,930,228 | |
| ROIV | Roivant Sciences Ltd. | +140,948 | 1,331,066 | $47,106,425 | |
| CELC | Celcuity Inc. | +118,523 | 329,101 | $34,430,546 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | +64,850 | 285,771 | $27,856,957 | |
| PRAX | Praxis Precision Medicines, Inc. | +41,087 | 83,528 | $27,964,339 | |
| AXSM | Axsome Therapeutics, Inc. | +29,643 | 218,415 | $53,461,439 | |
| ASND | Ascendis Pharma A/S | +28,577 | 104,877 | $27,972,793 | |
| NAMS | NewAmsterdam Pharma Co N.V. | +24,161 | 582,497 | $19,740,823 | |
| ABVX | Abivax S.A. | +24,020 | 489,889 | $65,282,608 | |
| INSM | INSMED Inc | +15,376 | 263,851 | $28,131,793 | |
| PVLA | Palvella Therapeutics, Inc. | +8,357 | 156,450 | $23,908,689 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
11 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| — | −374,948 | 138,822 | $18,425,844 | ||
| COGT | Cogent Biosciences, Inc. | −345,058 | 602,281 | $23,308,274 | |
| — | −344,046 | 26,298 | $0 | ||
| XENE | Xenon Pharmaceuticals Inc. | −186,644 | 600,200 | $36,228,072 | |
| MIRM | Mirum Pharmaceuticals, Inc. | −182,413 | 218,051 | $25,527,230 | |
| SRRK | Scholar Rock Holding Corp | −175,163 | 271,227 | $14,917,485 | |
| KYMR | Kymera Therapeutics, Inc. | −152,139 | 102,533 | $11,757,459 | |
| BBIO | BridgeBio Pharma, Inc. | −62,354 | 633,364 | $47,172,950 | |
| RVMD | Revolution Medicines, Inc. | −53,069 | 415,307 | $77,778,694 | |
| UTHR | UNITED THERAPEUTICS Corp | −19,794 | 84,932 | $46,018,705 | |
| QURE | uniQure N.V. | −6,564 | 608,925 | $28,047,085 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
5 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| PCVX | Vaxcyte, Inc. | 443,836 | $25,800,186 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 154,018 | $17,100,618 | |
| INBX | Inhibrx Biosciences, Inc. | 164,783 | $15,613,189 | |
| ORKA | Oruka Therapeutics, Inc. | 155,343 | $14,783,993 | |
| SION | Sionna Therapeutics, Inc. | 110,493 | $4,860,587 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
7 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| IDYA | IDEAYA Biosciences, Inc. | 873,838 | $29,116,282 | |
| FULC | Fulcrum Therapeutics, Inc. | 2,256,109 | $17,304,356 | |
| VERA | Vera Therapeutics, Inc. | 422,023 | $16,977,985 | |
| NTRA | Natera, Inc. | 81,077 | $16,214,589 | |
| OLMA | Olema Pharmaceuticals, Inc. | 768,662 | $11,460,750 | |
| MLTX | MoonLake Immunotherapeutics | 315,563 | $5,882,094 | |
| — | 326,694 | $0 | ||
| No positions match the current search. | ||||
31 tracked positions ·
$931,467,794 total
· filing declares
31 positions · $934,715,611
· as of Jun 30, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| RVMD |
Revolution Medicines, Inc.
Healthcare
|
Reduced | 415,307 | $77,778,694 | 8.35% | |
| ABVX |
Abivax S.A.
Healthcare
|
Added | 489,889 | $65,282,608 | 7.01% | |
| AXSM |
Axsome Therapeutics, Inc.
Healthcare
|
Added | 218,415 | $53,461,439 | 5.74% | |
| ELVN |
Enliven Therapeutics, Inc.
Healthcare
|
Added | 954,360 | $48,433,770 | 5.20% | |
| BBIO |
BridgeBio Pharma, Inc.
Healthcare
|
Reduced | 633,364 | $47,172,950 | 5.06% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Added | 1,331,066 | $47,106,425 | 5.06% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Reduced | 84,932 | $46,018,705 | 4.94% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Added | 527,412 | $44,930,228 | 4.82% | |
| XENE |
Xenon Pharmaceuticals Inc.
Healthcare
|
Reduced | 600,200 | $36,228,072 | 3.89% | |
| CELC |
Celcuity Inc.
Healthcare
|
Added | 329,101 | $34,430,546 | 3.70% | |
| VRDN |
Viridian Therapeutics, Inc.\DE
Healthcare
|
Added | 1,670,000 | $30,677,900 | 3.29% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 263,851 | $28,131,793 | 3.02% | |
| QURE |
uniQure N.V.
Healthcare
|
Reduced | 608,925 | $28,047,085 | 3.01% | |
| ASND |
Ascendis Pharma A/S
Healthcare
|
Added | 104,877 | $27,972,793 | 3.00% | |
| PRAX |
Praxis Precision Medicines, Inc.
Healthcare
|
Added | 83,528 | $27,964,339 | 3.00% | |
| DNTH |
Dianthus Therapeutics, Inc. /DE/
Healthcare
|
Added | 285,771 | $27,856,957 | 2.99% | |
| PCVX |
Vaxcyte, Inc.
Healthcare
|
NEW | 443,836 | $25,800,186 | 2.77% | |
| MIRM |
Mirum Pharmaceuticals, Inc.
Healthcare
|
Reduced | 218,051 | $25,527,230 | 2.74% | |
| PVLA |
Palvella Therapeutics, Inc.
Healthcare
|
Added | 156,450 | $23,908,689 | 2.57% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Reduced | 602,281 | $23,308,274 | 2.50% | |
| ERAS |
Erasca, Inc.
Healthcare
|
Added | 1,221,721 | $22,381,928 | 2.40% | |
| ORIC |
Oric Pharmaceuticals, Inc.
Healthcare
|
Held | 2,017,284 | $21,847,185 | 2.35% | |
| NAMS |
NewAmsterdam Pharma Co N.V.
Healthcare
|
Added | 582,497 | $19,740,823 | 2.12% | |
|
|
Reduced | 138,822 | $18,425,844 | 1.98% | ||
| RYTM |
Rhythm Pharmaceuticals, Inc.
Healthcare
|
NEW | 154,018 | $17,100,618 | 1.84% | |
| INBX |
Inhibrx Biosciences, Inc.
Healthcare
|
NEW | 164,783 | $15,613,189 | 1.68% | |
| SRRK |
Scholar Rock Holding Corp
Healthcare
|
Reduced | 271,227 | $14,917,485 | 1.60% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 155,343 | $14,783,993 | 1.59% | |
| KYMR |
Kymera Therapeutics, Inc.
Healthcare
|
Reduced | 102,533 | $11,757,459 | 1.26% | |
| SION |
Sionna Therapeutics, Inc.
Healthcare
|
NEW | 110,493 | $4,860,587 | 0.52% | |
|
|
Reduced | 26,298 | $0 | 0.00% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.